AMSTERDAM, the Netherlands—In patients with sinus node dysfunction treated with dual-chamber pacemakers, minimizing atrial pacing doesn’t lower the likelihood of developing atrial fibrillation (AF) ...
Please provide your email address to receive an email when new articles are posted on . Rate-modulated pacing at 60 bpm did not reduce AF incidence vs. nonadaptive pacing at 40 bpm in patients with ...
Minimizing atrial pacing does not alter the risk of atrial fibrillation (AF) associated with sinus node dysfunction (SND), suggest results of a trial that randomly assigned patients with SND who had ...
Amsterdam, Netherlands – 28 Aug 2023: Minimising atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late breaking research presented in a Hot Line ...
AMSTERDAM -- Reducing atrial pacing didn't help prevent atrial fibrillation (Afib, or AF) in patients with sinus node dysfunction but did increase risk of fainting, the DANPACE II trial showed. The ...
Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.
Treatment of supraventricular arrhythmias varies according to rhythm, rate, and hemodynamic stability. Therapeutic modalities include pharmacologic therapy, electrical cardioversion, ablation, and/or ...
Two first-in-human studies presented at the Heart Rhythm Society meeting reported strong early safety and efficacy results for novel atrial fibrillation devices, including a nanosecond pulsed field ...
NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...
NEW ORLEANS, LA—Rate-adaptive atrial pacing to increase heart rate during exercise is not a useful strategy in patients who have heart failure with preserved ejection fraction (HFpEF) and chronotropic ...
When transvenous pacing is unsuitable, leadless cardiac pacemaker implantation can be used during the evidence generation period for dual-chamber pacing or right atrial pacing alone for ...